Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule

Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule

Submitted by admin on November 7, 2023 - 10:05am
Source: 
BioSpace
News Tags: 
Novartis
Chong Kun Dang Pharmaceutical
small molecule drugs
Headline: 
Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule
snippet: 

Novartis on Monday inked a technology export contract with Korean biotech company Chong Kun Dang Pharmaceutical for an early-stage HDAC6 Inhibitor, according to Korea Biomedical Review.

Do Not Allow Advertisers to Use My Personal information